S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.14 (-1.04%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.66 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.14 (-1.04%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.66 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.14 (-1.04%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.66 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.14 (-1.04%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.66 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
OTCMKTS:ALIOF

ALIOF (ALIOF) Stock Price, News & Analysis

$278.50
0.00 (0.00%)
(As of 09/27/2022)
Today's Range
$278.50
$278.50
50-Day Range
$278.50
$278.50
52-Week Range
$138.01
$286.30
Volume
N/A
Average Volume
924 shs
Market Capitalization
$29.89 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ALIOF stock logo

About ALIOF Stock (OTCMKTS:ALIOF)

Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland.

ALIOF Stock Price History

ALIOF Stock News Headlines

See More Headlines
Receive ALIOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALIOF and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/16/2015
Today
2/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & Botanicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:ALIOF
CIK
N/A
Employees
N/A
Year Founded
1997

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$29.89 billion
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Nicholas Franco
    Chief Business Development Officer & EVP

Should I Buy ALIOF Stock? ALIOF Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of ALIOF was last updated on Tuesday, February 6, 2024 at 8:29 PM.

Pros

Here are some ways that investors could benefit from investing in ALIOF:

  • Recent developments indicate positive growth potential for ALIOF.
  • ALIOF's latest product, ALIOF 15, has received positive reviews and is expected to drive sales.
  • The current stock price of ALIOF is favorable for investors looking for potential gains.
  • ALIOF has shown consistent financial performance in recent periods, indicating stability.
  • ALIOF's strong market position and brand recognition provide a competitive advantage.

Cons

Investors should be bearish about investing in ALIOF for these reasons:

  • ALIOF faces potential market competition from other industry players.
  • Fluctuations in the global economy may impact ALIOF's financial performance.
  • ALIOF's reliance on a specific market segment may pose risks in case of market shifts.
  • Regulatory changes or legal issues could affect ALIOF's operations and profitability.
  • ALIOF's stock price may be subject to volatility due to market conditions.














ALIOF Stock Analysis - Frequently Asked Questions

How have ALIOF shares performed in 2024?

ALIOF's stock was trading at $278.50 on January 1st, 2024. Since then, ALIOF shares have increased by 0.0% and is now trading at $278.50.
View the best growth stocks for 2024 here
.

How were ALIOF's earnings last quarter?

ALIOF (OTCMKTS:ALIOF) released its quarterly earnings data on Monday, February, 16th. The company reported $0.87 earnings per share for the quarter, missing the consensus estimate of $1.09 by $0.22. The business had revenue of $501.50 million for the quarter, compared to analyst estimates of $546.30 million.

How do I buy shares of ALIOF?

Shares of ALIOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ALIOF) was last updated on 2/20/2024 by MarketBeat.com Staff